Close
Novotech
Jabsco PureFlo 21 Single Use

Qualicaps to invest $26m for Whitsett facility expansion

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline

AbbVie has entered into a global licensing agreement with...

Novo Nordisk OpenAI Partnership Accelerates Drug Development

Danish pharmaceutical major Novo Nordisk has entered into a...

Smart Sensors Elevating Pharma Process Control Systems

The deployment of intelligent sensing technology is fundamentally reshaping how pharmaceutical manufacturers manage complex production environments. By providing granular, real-time data at critical control points, these advanced instruments allow for instantaneous process adjustments, ensuring that every batch meets the most rigorous standards of quality and safety.
- Advertisement -

Pharmaceutical manufacturer Qualicaps will invest $26m to expand its facility in Whitsett, North Carolina in the US.

Under the expansion plans, the firm will also add additional 100,000 ft² building space. The project will be funded by the Guilford County Board of Commissioners and the State of North Carolina, which are providing economic development incentive grants of $272,805 and $235,000 respectively.

Greensboro Economic Development Alliance president Dan Lynch said Qualicaps decision to expand their manufacturing operations validates the firm’s industry cluster strategy.

“Qualicaps represents two of our five clusters; life science and innovative manufacturing. By expanding in Guilford County they are able to benefit from our skilled workforce and leverage comprehensive training programs through GTCC,” Lynch added.

Qualicaps is a wholly owned subsidiary of Qualicaps Group, which is a manufacturer and supplier of two-piece medical and nutrition grade gelatin capsules.

 

Latest stories

Related stories

AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline

AbbVie has entered into a global licensing agreement with...

Novo Nordisk OpenAI Partnership Accelerates Drug Development

Danish pharmaceutical major Novo Nordisk has entered into a...

Smart Sensors Elevating Pharma Process Control Systems

The deployment of intelligent sensing technology is fundamentally reshaping how pharmaceutical manufacturers manage complex production environments. By providing granular, real-time data at critical control points, these advanced instruments allow for instantaneous process adjustments, ensuring that every batch meets the most rigorous standards of quality and safety.

Next Gen Filtration Systems for Pharma Facilities

The evolution of filtration technology is playing a critical role in enhancing the safety and efficiency of pharmaceutical manufacturing. Next-generation filtration systems—featuring advanced membrane materials, automated integrity testing, and single-use designs—provide superior contamination control and operational agility, ensuring that modern drug products meet the most stringent sterility and purity requirements.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »